advertisement
Ross AG 19
Showing records 1 to 19 | Display all abstracts from Ross AG108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Salowe RJ
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Yue J
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Chen Y
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Khan RS
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Zenebe-Gete S
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Duong TT
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Lee R
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Dine KE; Cui QN
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Gudiseva HV; Di Rosa I
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
O'Neill N
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Ross AG
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Aravand P
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Cui QN
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Liu T
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Miller-Ellis E
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Chaqour B
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Addis V
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Shindler KS; Ross AG
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Sankar PS; Daniel E; Ying GS; O'Brien JM
BMJ open ophthalmology 2023; 8:
